Skip to main content
. 2024 Apr 9;15:1383494. doi: 10.3389/fneur.2024.1383494

Figure 2.

Figure 2

Delayed infarct volume growth is the target of neuroprotection in animal stroke, but most stroke patients with successful recanalization do not offer this target. (A,B) Infarct growth after tMCAO in rodents without neuroprotective treatment. (A) Black and green lines connect the mean infarct volumes of untreated animals determined at timepoints 1 and 2 in each individual study. (B) Each cross represents the change in mean infarct volumes in an individual study. The median change in mean infarct volumes was 74%. (C,D) Infarct growth after tMCAO in rodents with neuroprotective treatment. (C) Black and green lines connect the mean infarct volumes of treated animals determined at timepoints 1 and 2 in each individual study. (D) Each cross represents the change in mean infarct volumes in an individual study. The median change in mean infarct volumes was 23%. (E,F) Infarct growth in stroke patients with TICI 2b-3 thrombectomy. (E) Black lines connect the infarct volumes at timepoints 1 and 2 in each patient. The red line represents an overall regression line given by the fixed effects of the mixed model. (B) Each cross represents the infarct volume growth in a patient. The median change in infarct volumes was only 2%.